Immunogenicity and safety of influenza vaccine in patients with lung cancer receiving immune checkpoint inhibitors: A single-center prospective cohort study

20234 citationsJournal Articlehybrid Open Access

Authors

Kei Nakashima · Kameda Medical Center

Yuya Homma · Kameda Medical Center

Jumpei Taniguchi · Kameda Medical Center

Norihiko Kubota · Kameda Medical Center

Ayumu Otsuki · Kameda Medical Center

Hiroyuki Ito · Kameda Medical Center

Yoshihito Otsuka ·

Abstract

Overall, influenza vaccination in patients with lung cancer receiving ICIs showed acceptable immunogenicity and safety, thus supporting annual influenza vaccination in this population.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Infection and Chemotherapy

Volume 29, Issue 11, pp. 1038-1045

DOI: 10.1016/j.jiac.2023.07.008

Field-Weighted Citation Impact: 0.92